Evidence map›Paper›PMID 41699270›Full record

ArticleNature microbiology2026

Human immunodeficiency virus-associated gut microbiome impacts systemic immunodeficiency and susceptibility to opportunistic gut infection.

Stavros Bashiardes, Melina Heinemann, Lorenz Adlung, Rafael Valdés-Mas, Jemal Ali Mahdi, Samuel P Nobs, Timur Tuganbaev, Takahiro Yamada, Max Horn, Uria Mor and 32 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Stavros Bashiardes *Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0001-6002-8644
Melina Heinemann *Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Lorenz Adlung *Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-0971-2309
Rafael Valdés-Mas *Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-0737-5425
Jemal Ali Mahdi *Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Samuel P NobsDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-0627-892X
Timur TuganbaevDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-4940-0000
Takahiro YamadaDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Max HornDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Uria MorDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Yotam CohenDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Sarah IsraelHadassah AIDS Center, Clinical Microbiology & Infectious Diseases Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.ORCID http://orcid.org/0000-0001-5646-0071
Maya KoremHadassah AIDS Center, Clinical Microbiology & Infectious Diseases Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Yonatan OsterHadassah AIDS Center, Clinical Microbiology & Infectious Diseases Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.ORCID http://orcid.org/0000-0002-1050-1648
Karen Olshtain-PopsHadassah AIDS Center, Clinical Microbiology & Infectious Diseases Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Efrat Orenbuch-HarrochHadassah AIDS Center, Clinical Microbiology & Infectious Diseases Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Muhammed Dervis ArslanDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Shahar MolinaDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Maya ZurDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Shimrit Eliyahu-MillerDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Aurélie BukimerDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Sara FedericiDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-3663-5142
Mally Dori-BachashDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Nira AmarDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Daniel ElbirtAllergy, Clinical Immunology and HIV Unit, Kaplan Medical Center, Rehovot, Israel.ORCID http://orcid.org/0000-0002-9056-236X
Ronit Cohen-PoradosuTel-Aviv Sourasky Medical Center, Crusaid Kobler AIDS Center, Tel Aviv, Israel.
Dan TurnerTel-Aviv Sourasky Medical Center, Crusaid Kobler AIDS Center, Tel Aviv, Israel.
Tiberiu HershcoviciDepartment of Gastroenterology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Elez VainerDepartment of Gastroenterology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Noa StettnerDepartment of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.
Alon HarmelinDepartment of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.
Hailay GebremeskelDepartment of Internal Medicine, Collage of Health Sciences, Mekelle University, Mekelle, Ethiopia.
Yazezew KebedeDepartment of Internal Medicine, Collage of Health Sciences, Mekelle University, Mekelle, Ethiopia.
Sabine SchmidtDivision of Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Niv ZmoraSchool of Medicine, Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.ORCID http://orcid.org/0000-0001-7928-316X
Arunraj DhamodaranDivision of Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-7711-9593
Jens PuschhofDivision of Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-9275-4034
Zvi BentwichDepartment of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer Sheba, Israel.
Hagit ShapiroDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Ido AmitDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-2968-877X
Hila ElinavHadassah AIDS Center, Clinical Microbiology & Infectious Diseases Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. hila.elinav@gmail.com.ORCID http://orcid.org/0000-0001-9046-8130
Eran ElinavDepartment of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel. eran.elinav@weizmann.ac.il.ORCID http://orcid.org/0000-0002-5775-2110

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiome of people living with human immunodeficiency virus (PLWH) has been characterized, but its role in influencing host immunity and associated clinical features are unclear. Here we used shotgun metagenomics to characterize the faecal microbiome of two geographically distinct cohorts of PLWH and healthy controls in Israel and Ethiopia. We uncovered disease-specific, geographically divergent microbial patterns including a shift from Bacteroides to Prevotella species in an Israeli cohort and multiple Enterobacteriaceae species including Escherichia coli and Klebsiella quasivariicola in an Ethiopian cohort. We identified correlations between human immunodeficiency virus-related dysbiosis and the extent of systemic immunodeficiency, as proxied by peripheral CD4

Indexed as

Gastrointestinal MicrobiomeHIV InfectionsOpportunistic InfectionsAnimalsBacteriaCD4 Lymphocyte CountCD4-Positive T-LymphocytesCohort StudiesCryptosporidiosisDisease SusceptibilityDysbiosisEthiopiaFecal Microbiota TransplantationFecesFemaleHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.